慢性心不全患者の健康状態に対する運動トレーニングの効果:HF-ACTIONランダム化対照試験

Kathryn E Flynn¹, Ileana L Piña, David J Whellan

¹Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA. kathryn.flynn@duke.edu

JAMA

|April 9, 2009

まとめ

運動トレーニングは,心不全患者の健康状態を大幅に改善します. 自己報告された健康上のこれらの利益は,早期に観察され,時間とともに持続し,貴重な非薬理学的介入を提供しました.

科学分野:

心臓病学心臓病学
運動生理学運動生理学
クリニック・トライアル臨床試験

背景:

心不全患者の健康状態に対する運動トレーニングの影響に関する以前の研究は,矛盾する結果をもたらしました.
心不全は,世界中で何百万人もの人に影響し,効果的な管理戦略を必要とします.

研究の目的:

心不全と診断された患者の健康状態の改善におけるエアロビック運動トレーニングの有効性を評価する.

主な方法:

2331人の心不全患者で,左心室エジェクション分数 ≤35% を含む多センター,ランダム化制御試験.
患者は通常のケアと構造化されたエアロビック運動トレーニング,または通常のケアのみを受診しました.
健康状態は4年間のカンザスシティ心筋組織病質アンケート (KCCQ) を使用して評価されました.

主要な成果:

運動トレーニンググループは,KCCQスコアの統計的に有意な改善を3ヶ月後に示した (1.93ポイント増加,P < .001).
自己報告した健康状態の改善は,4年間の追跡期間中維持された.
重要なサブグループ相互作用は検出されず,広範な適用性を示しています.

結論:

エアロビックエクササイズトレーニングは,心不全患者の自己報告された健康状態において,控えめだが有意な改善をもたらします.
運動トレーニングの利点は,早期に明らかになり,長期にわたって持続し,標準的なケアに統合することを支援します.

さらに関連する動画

07:49

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models

Published on: July 21, 2023

関連する概念動画

01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...

01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...

01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...

関連する実験動画